Matrix metalloproteinases (MMP-1, MMP-2, MMP-3 and MMP-9, and TIMP-1, TIMP-2 and TIMP-3) and markers for vascularization in functioning and non-functioning bleb capsules of glaucoma drainage implants

Acta Ophthalmologica

Volumn 93, Issue 5, 2015, Pages 450-456

  Välimäki, Juha ^a   Uusitalo, Hannu ^b,c  

^a PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

angiogenesis; antiglaucoma medication; extracellular matrix; glaucoma tube surgery

Indexed keywords

CD31 ANTIGEN; CORTICOSTEROID; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 16; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; BIOLOGICAL MARKER; MATRIX METALLOPROTEINASE; STROMELYSIN; TIMP1 PROTEIN, HUMAN; TIMP2 PROTEIN, HUMAN; TIMP3 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ANGIOGENESIS; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONING GLAUCOMA DRAINAGE IMPLANT CAPSULE; GLAUCOMA DRAINAGE IMPLANT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; INTRAOCULAR PRESSURE; LENS CAPSULE; MALE; NON FUNCTIONING GLAUCOMA DRAINAGE IMPLANT CAPSULE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UVEITIS; COMPARATIVE STUDY; CONJUNCTIVA; ENZYME IMMUNOASSAY; GLAUCOMA; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION; YOUNG ADULT;

AGED; ANTIGENS, CD31; BIOMARKERS; CONJUNCTIVA; FEMALE; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANTS; HUMANS; IMMUNOENZYME TECHNIQUES; INTRAOCULAR PRESSURE; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, SECRETED; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES; YOUNG ADULT;

EID: 84937737993     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12654     Document Type: Article

References (32)

1. Abdul-Hussien H, Soekhoe RG, Weber E, et al., (2007): Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol 170: 809-817.
2. Amour A, Slocombe PM, Webster A, et al., (1998): TNF-Alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435: 39-44.
3. Arkell J, &, Jackson CJ, (2003): Constitutive secretion of MMP9 by early-passage cultured human endothelial cells. Cell Biochem Funct 21: 381-386.
4. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, &, Engler JA, (1993): Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250.
5. Brown D, Hamdi H, Bahri S, &, Kenney MC, (1994): Characterization of an endogenous metalloproteinase in human vitreous. Curr Eye Res 13: 639-647.
6. Chintala SK, Wang N, Diskin S, Mattox C, kagemann L, Fini ME, &, Schuman JS, (2005): matrix metalloproteinase gelatinase B (MMP-9) in associated with leaking glaucoma filtering blebs. Exp Eye Res 81: 429-436.
7. Dollery CM, McEwan JR, &, Henney AM, (1995): Matrix metalloproteinases and cardiovascular disease. Circ Res 77: 863-868.
8. Gedde SJ, Schiffman JC, Feuer WJ, Parrish RK, Heuer DK, &, Brandt JD, (2005): The tube versus trabeculectomy study: design and baseline characteristics of study patients. Am J Ophthalmol 140: 275-287.
9. Helin-Toiviainen M, Rönkkö S, Puustjärvi T, Rekonen P, Ollikainen M, &, Uusitalo H, (2014): Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients. Acta Ophthalmol 93: 165-171.
10. Ito T, Obguro H, Mamiya K, Obguro I, &, Nakazawa M, (2006): Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissue. Invest Ophthalmol Vis Sci 47: 823-830.
11. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, &, Itohara S, (1998): Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58: 1048-1051.
12. Kashiwagi M, Tortorella M, Nagase H, &, Brew K, (2001): TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAMTS5). J Biol Chem 276: 12501-12504.
13. Kerrigan JJ, Mansell JP, &, Sandy JR, (2000): Matrix turnover. J Orthod 27: 227-233.
14. Kim H, Cho HJ, Kim SW, et al., (2010): CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res 107: 602-614.
15. Kim CH, Lee JH, Won Jh, &, Cho MK, (2011): Mesenchymal stem cells improve wound healing in vivo via early activation of matrix metalloproteinase-9 and vascular endothelial growth factor. J Korean Med Sci 26: 726-733.
16. Loechel F, Fox JW, Murphy G, Albrechtsen R, &, Wewer UM, (2000): ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 278: 511-515.
17. Määttä M, Tervahartiala T, Vesti E, Airaksinen J, &, Sorsa T, (2006): Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma. J Glaucoma 15: 229-237.
18. Matrisian LM, (1992): The matrix-degrading metalloproteinases. Bio Assays 14: 455-463.
19. McCluskey P, Molteno A, Wakefield D, &, Di Girolamo N, (2009): Otago glaucoma surgery outcome study: the pattern of expression of MMPs and TIMPs in bleb capsules surrounding Molteno implants. Invest Ophthalmol Vis Sci 50: 2161-2164.
20. Mietz H, Schlotzer-Schrehardt U, Strassfeld C, &, Krieglstein GK, (2001): Effect of latanoprost and timolol on histopathology of rabbit conjunctiva. Invest Ophthalmol Vis Sci 42: 679-687.
21. Molteno ACB, Fucik M, Dempster AG, &, Bevin TH, (2003): Otago Glaucoma Surgery Outcome Study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation. Ophthalmology 110: 2198-2206.
22. Molteno ACB, Suter AJ, Fenwick M, Bevin TH, &, Dempster AG, (2006): Otago glaucoma surgery outcome study: cytology and immunohistochemical staining of bleb capsules around Moleteno implants. Invest Ophthalmol Vis Sci 47: 1975-1981.
23. Nagase H, Visse R, &, Murphy G, (2006): Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573.
24. Oberringer M, Jennewein M, Motsch SE, Pohlemann T, &, Seekamp A, (2005): Different cell cycle responses of wound healing protagonists to transient in vitro hypoxia. Histochem Cell Biol 123: 595-603.
25. Pusztaszeri MP, Seelentag W, &, Bosman FT, (2006): Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54: 385-395.
26. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, Baker A, &, Anand-Apte B, (2003): A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9: 407-415.
27. Rönkkö S, Rekonen P, Kaarniranta K, Puustjärvi T, Teräsvirta M, &, Uusitalo H, (2007): Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-Angle glaucoma and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 245: 697-704.
28. Stetler-Stevenson WG, (2001): The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am 10: 383-392.
29. Terai N, Schlötzer-Schrehardt U, Lampel J, Böhm AG, Rummelt C, Schmidt E, &, Pillunat LE, (2009): Effect of latanoprost and timolol on the histopathology of the human conjunctiva. Br J Ophthalmol 93: 219-224.
30. Thompson RW, Geraghty PJ, &, Lee JK, (2002): Abdominal aortic aneurysms: basic mechanisms and clinical mechanisms and implications. Curr Probl Surg 39: 110-230.
31. Välimäki J, &, Uusitalo H, (2013): Immunohistochemical analysis of extracellular matrix bleb capsules of functioning and non-functioning glaucoma drainage implants. Acta Ophthalmol 92: 524-528.
32. Välimäki J, Tuulonen A, &, Airaksinen PJ, (1997): Capsule excision after failed Molteno surgery. Ophthalmic Surg Lasers 28: 382-386.